This Korean-language brochure gives patients information on buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This guide helps counselors improve their skills in leading group therapy sessions for substance use treatment. The guide discusses types of group therapy, confidentiality, client placement, group development, stages of treatment, how-to tips, training, and supervision.

This manual describes brief intervention and therapy techniques for the treatment of alcohol and drug misuse.

This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.

This pocket guide is designed as a quick reference for information about medication-assisted treatment for alcohol use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.

These guidelines are for clinicians who lead group therapy sessions for substance use disorder treatment. It describes types of group therapy, and advantages of group therapy. The guide also provides client placement criteria, and techniques for group development and leadership.

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status.

This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. Access state barometer reports.

This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder. It covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.